As Galectin-1 plays a role in the prognosis and treatment of melanoma, we critically reviewed the published information on its role within immune, endothelial, and stromal cells, the influence of Gal-1 on cancer biology, specifically within melanoma, therapeutic strategies to target Gal-1, and identified key gaps in current therapies and research. This evidence concerns the gene GAL and cancer.